Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Sagimet Biosciences Inc., 3 years.
Sagimet Biosciences Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 21, 2025 | Ardelyx Inc. | Open-market sale | −5,995 | $5.54 | $33,212 |
| Aug 21, 2025 | Ardelyx Inc. | Open-market sale | −5,841 | $5.93 | $34,637 |
| May 20, 2025 | Ardelyx Inc. | Open-market sale | −5,992 | $4.08 | $24,447 |
| Feb 25, 2025 | Ardelyx Inc. | Grant or award | +136,680 | — | — |
| Feb 20, 2025 | Ardelyx Inc. | Open-market sale | −4,291 | $5.62 | $24,115 |
| Nov 20, 2024 | Ardelyx Inc. | Open-market sale | −7,046 | $4.79 | $33,750 |
| Aug 20, 2024 | Ardelyx Inc. | Open-market sale | −7,089 | $5.86 | $41,542 |
| May 21, 2024 | Ardelyx Inc. | Open-market sale | −6,927 | $7.81 | $54,100 |
| May 6, 2024 | Ardelyx Inc. | Option exercise | +110,250 | $0.99 | $109,148 |
| May 6, 2024 | Ardelyx Inc. | Option exercise | +109,687 | $2.75 | $301,639 |
| May 6, 2024 | Ardelyx Inc. | Open-market sale | −64,233 | $8.87 | $569,747 |
| May 6, 2024 | Ardelyx Inc. | Open-market sale | −219,937 | $8.88 | $1,953,041 |
| May 3, 2024 | Ardelyx Inc. | Open-market sale | −45,000 | $9.00 | $405,000 |
| Mar 20, 2024 | Ardelyx Inc. | Open-market sale | −86,000 | $7.73 | $664,780 |
| Feb 20, 2024 | Ardelyx Inc. | Open-market sale | −4,432 | $8.75 | $38,780 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.